Transthyretin Cardiac Amyloidosis: The Truth Is Unfolding Transthyretin Cardiac Amyloidosis: The Truth Is Unfolding

New technologies have determined that transthyretin cardiac amyloidosis, once thought to be rare and untreatable, is more common than previously thought, and novel therapeutic options are emerging.Circulation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news